Neuland Laboratories Limited (NSE:NEULANDLAB)

Neuland Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	4,504	766.7	1,319	875.75	454.16	50.91
Short-Term Investments	-	-	1,077	-	-	33.77
Cash & Short-Term Investments	4,504	766.7	2,396	875.75	454.16	84.68
Cash Growth	166.98%	-68.00%	173.61%	92.83%	436.31%	-4.76%
Accounts Receivable	2,943	5,425	3,162	3,760	3,687	2,380
Other Receivables	-	105.69	79.78	70.45	31.6	35.16
Receivables	2,943	5,531	3,242	3,830	3,719	2,415
Inventory	5,521	5,103	3,858	3,504	2,792	2,652
Prepaid Expenses	-	139.79	117.18	111.41	105.38	74.16
Other Current Assets	930.11	3,291	1,782	889.07	538.4	582.18
Total Current Assets	13,899	14,831	11,395	9,211	7,609	5,808
Property, Plant & Equipment	12,785	11,018	7,183	5,686	4,980	4,866
Long-Term Investments	19.82	19.82	15.29	12.79	5.25	4.97
Goodwill	2,795	2,795	2,795	2,795	2,795	2,795
Other Intangible Assets	43.18	62.66	48.54	24.58	13.01	21.2
Other Long-Term Assets	754.57	575.13	362.74	596.7	395.86	340.41
Total Assets	30,296	29,301	21,799	18,326	15,798	13,835

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	2,086	2,691	2,522	1,920	1,710	1,174
Accrued Expenses	-	1,063	841.95	1,060	626.39	451.21
Short-Term Debt	-	-	-	-	111.58	922.15
Current Portion of Long-Term Debt	384.82	356.66	452.83	375.86	361.07	344.84
Current Portion of Leases	74.94	49.64	25.1	36.79	30.92	26.46
Current Income Taxes Payable	119.23	181.56	0.89	0.81	104.02	-
Other Current Liabilities	3,521	2,760	814.07	883.53	1,446	713.08
Total Current Liabilities	6,186	7,102	4,657	4,277	4,390	3,632
Long-Term Debt	2,007	1,609	907.27	449.21	742.46	1,042
Long-Term Leases	956.1	996.95	186.18	92.03	38.48	69.4
Pension & Post-Retirement Benefits	-	101.98	23.72	36.54	70.08	86.92
Long-Term Deferred Tax Liabilities	679.93	689.64	728.22	604.39	582.99	566.99
Other Long-Term Liabilities	169.49	56.63	48.5	39.56	33.11	32.52
Total Liabilities	9,998	10,557	6,551	5,499	5,857	5,430

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	129.01	128.3	128.3	128.3	128.3	128.3
Additional Paid-In Capital	-	4,978	4,978	4,978	4,978	4,978
Retained Earnings	-	13,711	10,225	7,804	4,931	3,360
Comprehensive Income & Other	20,168	-72.6	-83.24	-82.79	-96.38	-61.31
Shareholders' Equity	20,297	18,745	15,248	12,827	9,941	8,405
Total Liabilities & Equity	30,296	29,301	21,799	18,326	15,798	13,835

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	3,423	3,013	1,571	953.9	1,284	2,405
Net Cash (Debt)	1,081	-2,246	824.76	-78.14	-830.34	-2,321
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	84.28	-175.06	64.28	-6.09	-64.72	-180.88
Filing Date Shares Outstanding	12.83	12.83	12.83	12.83	12.83	12.83
Total Common Shares Outstanding	12.83	12.83	12.83	12.83	12.83	12.83
Working Capital	7,713	7,729	6,738	4,934	3,219	2,176
Book Value Per Share	1582.09	1461.02	1188.48	999.78	774.83	655.11
Tangible Book Value	17,459	15,887	12,405	10,008	7,133	5,589
Tangible Book Value Per Share	1360.90	1238.32	966.88	780.04	555.99	435.64
Land	-	506.78	330.91	287.48	107.43	107.43
Buildings	-	2,682	2,342	2,049	1,820	1,722
Machinery	-	7,999	6,554	5,336	4,635	4,337
Construction In Progress	-	2,095	445.53	458.91	405.66	204.57
Leasehold Improvements	-	81.74	-	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Nov 3, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error